Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 37 of 126 for:    "Acute Leukemia" | "Antimetabolites, Antineoplastic"

Pharmacokinetic and Pharmacodynamic Assessment of Treatment With CPX-351 (Cytarabine: Daunorubicin) Liposome for Injection in Acute Leukemias and MDS Patients With Moderate Hepatic Impairment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02269579
Recruitment Status : Withdrawn
First Posted : October 21, 2014
Last Update Posted : March 14, 2018
Sponsor:
Information provided by (Responsible Party):
Jazz Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : June 2017
Estimated Study Completion Date : June 2017